| Literature DB >> 27622291 |
Edwin J van Adrichem1,2,3, Saskia C van de Zande1, Rienk Dekker2,4, Erik A M Verschuuren3,5, Pieter U Dijkstra2,6, Cees P van der Schans1,2.
Abstract
BACKGROUND: Sufficient physical activity is important for solid organ transplant recipients (heart, lung, liver, kidney). However, recipients do not meet the recommended amount or required type of physical activity. The perceived barriers to and facilitators of physical activity in this population are largely unknown.Entities:
Mesh:
Year: 2016 PMID: 27622291 PMCID: PMC5021267 DOI: 10.1371/journal.pone.0162725
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Physical Activity for People with a Disability (PAD) model.
Reprinted from van der Ploeg et al., 2004 [34] under a CC BY license, with permission from Springer, original copyright 2004.
Participant characteristics.
| Transplanted organ | Disease before transplantation | Time since Tx (months) | Gender (M/F) | Age (years) | Immunosuppressive medication | Comorbidities | |
|---|---|---|---|---|---|---|---|
| 1 | Heart | DCM | 93 | M | 51 | Tacrolimus, mycophenolate mofetil | DM II |
| 2 | Heart | DCM | 63 | M | 41 | Prednison, ciclosporine | - |
| 3 | Heart | HCM | 43 | F | 56 | Prednison,tacrolimus, mycophenolate mofetil | Hyperthyroidism |
| 4 | Heart | Cong. AV-block | 23 | F | 21 | Tacrolimus, mycophenolate mofetil | - |
| 5 | Lung | COPD | 6 | F | 57 | Prednison,tacrolimus, mycophenolate mofetil | HT |
| 6 | Lung | PH | 8 | F | 50 | Prednison, tacrolimus | Reduced renal function |
| 7 | Lung | PH | 12 | M | 53 | Prednison,tacrolimus, mycophenolate mofetil | Hepatitis C, hypercholesterolemia, reduced renal function |
| 8 | Lung | COPD | 11 | M | 39 | Prednison,tacrolimus, mycophenolate mofetil | Hypercholesterolemia, reduced renal function |
| 9 | Liver | Autoimmune hepatitis | 18 | M | 70 | Prednison,tacrolimus, mycophenolate mofetil | DM II |
| 10 | Liver | PSC | 19 | M | 43 | Tacrolimus, mycophenolate mofetil | - |
| 11 | Liver | PBC | 144 | F | 63 | Prednison | Reduced renal function |
| 12 | Liver | Autoimmune hepatitis | 123 | M | 22 | Prednison,tacrolimus, mycophenolate mofetil | Osteoporosis |
| 13 | Kidney | IgA nephropathy | 15 | M | 45 | Prednison, mycophenolate mofetil | HT, hypercholesterolemia |
| 14 | Kidney | Amyloidosis | 6 | M | 54 | Prednison,tacrolimus, mycophenolate mofetil | Amyloidosis, hyperthyroidism |
| 15 | Kidney | Hypertensive emergency | 7 | F | 42 | Prednison,tacrolimus, mycophenolate mofetil | - |
| 16 | Kidney | Renal cysts | 11 | F | 52 | Prednison, mycophenolate mofetil, ciclosporine | Sjögren |
| Median | 16.5 | 9M/ 7F | 50.5 | ||||
| IQR | 8.8; 58.0 | 41.3; 55.5 |
PBC, primary biliary cholangitis; DCM, dilating cardiomyopathy; COPD, chronic obstructive pulmonary disease; PH, pulmonary hypertension; PSC, primary sclerosing cholangitis; HCM, hypertrophic cardiomyopathy; DM II, diabetes mellitus type II; HT, hypertension; IQR, interquartile range.
Overview distribution barriers to and facilitators of physical activity and solidity in the data.
| Barriers | ← | → | Facilitators | ||
|---|---|---|---|---|---|
| 1. | 2. | 3. | 4. | 5. | |
| Stronger | Physical limitations (15/75) | Energy level (12/45) | Coping (15/55) | Motivation (16/148) | |
| ↑ | Fear (9/20) | Self-efficacy (13/35) | Routine/habit (14/40) | Consequences of (in)activity (14/40) | |
| Comorbidity (8/26) | Expertise of personnel (13/26) | Goals/goal priority (13/88) | |||
| Bad weather (6/8) | Transplanted organ (10/29) | ||||
| ↓ | Post-transplant life-events (4/6) | Side-effects medication (6/12) | Social support (9/14) | ||
| Age (3/4) | Social role (5/19) | Strength (8/15) | |||
| Weaker | Financial resources (3/4) | Group activity (4/8) | Weight (5/13) | ||
Codes are classified on the continuum from barrier to facilitator (1. [red] absolute barriers; 2. [orange] themes being mentioned mainly as barriers but sometimes as a facilitator; 3. [yellow] themes being mentioned as a barrier or facilitator equally; 4. [light green] themes being mentioned mainly as facilitator but sometimes as a barrier; and 5 [green] absolute facilitators) and on the continuum of being a stronger or a weaker factor. The numbers in parenthesis indicate the number of interviews the code is represented in and the groundedness of the code (number of quotations linked to that particular code).
Overview of personal and environmental barriers and facilitators to physical activity in recipients of solid organ transplantation.
| | Physical limitations | |
| Lack of energy | Increased energy level | |
| Comorbidity | ||
| Lack of strength | Maintaining/increasing muscle strength | |
| Weight being a barrier | Wanting to lose weight/maintain weight | |
| Age | ||
| | Lack of motivation | Motivation |
| Lack of time | Reinforcement | |
| Other priorities | Fun/pleasure | |
| Fear (complications/injury) | Competition | |
| Coping | Coping | |
| Goals/goal priority | Goals/goal priority | |
| Post-transplant life-events | Self-efficacy | |
| | Routine/habit | Routine/habit |
| Consequences of (in)activity | ||
| Transplanted organ | ||
| | Lack of expertise personnel | Expertise personnel |
| Lack of social support | Social support | |
| Lack of group activity | Family/friends | |
| Social role | Professionals | |
| Group activity | ||
| | Bad weather | Having a dog (motivation) |
| | Side-effect medication | - |
| Financial resources |